<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To estimate the incidence, mortality and prevalence of most common <z:e sem="disease" ids="C0685938" disease_type="Neoplastic Process" abbrv="">gastrointestinal tract cancers</z:e> (esophageal, gastric and <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e>) in China in 2008 and to predict the related incidence and mortality in the next 20 years </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Data from 36 Chinese <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> registries and the Third National <z:hpo ids='HP_0011420'>Death</z:hpo> Survey in China (2004 - 2005) were used to estimate the incidence, mortality and 5-year prevalence of esophageal, gastric and <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> in China in 2008 </plain></SENT>
<SENT sid="2" pm="."><plain>Mathematical models were used to predict the incidence and mortality of these <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> in the next 20 years </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: In 2008, the incident cases of esophageal, gastric and <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> were estimated to be 259 235, 464 439 and 221 313, respectively, which totally accounted for one third of <z:hpo ids='HP_0000001'>all</z:hpo> the incident <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cases </plain></SENT>
<SENT sid="4" pm="."><plain>Age-standardized incidence rates of esophageal, gastric and <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> were estimated as 16.7/100 000, 29.9/100 000 and 14.2/100 000, respectively, while the mortality rates were 13.4/100 000, 22.3/100 000 and 6.9/100 000, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>The number of 5-year prevalent cases were estimated as 257 352 for <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e>, 680 824 for <z:hpo ids='HP_0012126'>gastric cancer</z:hpo> and 509 140 for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, which correspondingly ranked the seventh, first and third among <z:hpo ids='HP_0000001'>all</z:hpo> the number of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, respectively </plain></SENT>
<SENT sid="6" pm="."><plain>Till 2030, incident cases of these <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> would reach 484 923, 860 022 and 400 086, while <z:hpo ids='HP_0011420'>deaths</z:hpo> reach 412 916, 678 670 and 211 714, respectively </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: Esophageal, gastric and <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> had been the main digestive tract <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> in China, that causing serious health burden </plain></SENT>
<SENT sid="8" pm="."><plain>As dramatic increasing burden was predicted in the next two decades for these three <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, more attention needs to be paid accordingly </plain></SENT>
</text></document>